Company has no debt since last 5 years. (Source: Standalone Financials)
Amrutanjan Health Care Share Price
Amrutanjan Health Care ...
Amrutanjan Health Care share price insights
Company's annual revenue growth of 11.16% outperformed its 3 year CAGR of 8.3%. (Source: Standalone Financials)
Stock gave a 3 year return of 13.41% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company has spent less than 1% of its operating revenues towards interest expenses and 11.46% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Amrutanjan Health Care Ltd. share price moved down by -0.74% from its previous close of Rs 832.25. Amrutanjan Health Care Ltd. stock last traded price is 826.15
Share Price Value Today/Current/Last 826.15 Previous Day 832.25
Key Metrics
PE Ratio (x) | 56.10 | ||||||||||
EPS - TTM (₹) | 14.73 | ||||||||||
MCap (₹ Cr.) | 2,388.45 | ||||||||||
Sectoral MCap Rank | 64 | ||||||||||
PB Ratio (x) | 8.34 | ||||||||||
Div Yield (%) | 0.56 | ||||||||||
Face Value (₹) | 1.00 | ||||||||||
Beta Beta
| 1.41 | ||||||||||
VWAP (₹) | 829.12 | ||||||||||
52W H/L (₹) |
Amrutanjan Health Care Share Price Returns
1 Day | -0.74% |
1 Week | 8.95% |
1 Month | 10.37% |
3 Months | 18.3% |
1 Year | 35.7% |
3 Years | 13.41% |
5 Years | 188.81% |
Amrutanjan Health Care News & Analysis
NewsSmallcap Triumph! Edelweiss Financial Services, 4 more stocks surpass 100-day SMA
NewsKNR Constructions, PC Jeweller and 4 others small cap stocks cross 100 SMA
NewsAmrutanjan Health Care sinks 10% on whistleblower allegations
Updates on disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Announcements
Amrutanjan Health Care Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Amrutanjan Health Care Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 11.16% outperformed its 3 year CAGR of 8.3%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 11.46% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 88.19 132.61 120.76 103.26 81.55 Total Income Growth (%) -33.50 9.81 16.95 26.62 -22.43 Total Expenses 81.77 112.95 97.00 94.02 72.10 Total Expenses Growth (%) -27.60 16.45 3.16 30.42 -18.67 EBIT 6.41 19.65 23.76 9.24 9.45 EBIT Growth (%) -67.37 -17.29 157.29 -2.31 -42.67 Profit after Tax (PAT) 4.62 13.66 17.45 6.85 7.01 PAT Growth (%) -66.21 -21.72 154.77 -2.36 -44.74 EBIT Margin (%) 7.27 14.82 19.68 8.94 11.59 Net Profit Margin (%) 5.23 10.30 14.45 6.63 8.60 Basic EPS (₹) 1.60 4.72 6.05 2.36 2.40 All figures in Rs Cr, unless mentioned otherwise
Insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 366.87 362.09 349.87 274.27 205.35 Total Assets Growth (%) 1.32 3.49 27.56 33.56 9.46 Total Liabilities 78.38 71.32 84.74 58.71 45.92 Total Liabilities Growth (%) 9.90 -15.84 44.34 27.85 9.65 Total Equity 288.49 290.77 265.12 215.56 159.43 Total Equity Growth (%) -0.78 9.67 22.99 35.21 9.39 Current Ratio (x) 4.23 4.12 3.55 4.28 3.22 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 0.00 10.12 11.39 12.94 12.84 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 27.91 20.18 52.20 89.76 18.18 Net Cash used in Investing Activities 19.17 -2.48 -36.21 -87.76 -13.85 Net Cash flow from Financing Activities -48.27 -14.99 -16.70 -6.32 -11.69 Net Cash Flow -1.19 2.72 -0.72 -4.31 -7.36 Closing Cash & Cash Equivalent 3.71 4.90 2.19 2.91 7.22 Closing Cash & Cash Equivalent Growth (%) -24.29 124.26 -24.75 -59.77 -50.49 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 15.58 13.69 25.34 28.38 15.73 Return on Capital Employed (%) 20.91 17.96 33.42 37.09 20.85 Return on Assets (%) 12.25 11.00 19.20 22.31 12.21 Interest Coverage Ratio (x) 434.97 764.38 195.78 172.15 176.63 Asset Turnover Ratio (x) 1.16 1.07 1.30 1.39 1.33 Price to Earnings (x) 39.84 42.19 34.60 27.17 38.46 Price to Book (x) 6.20 5.78 8.75 7.71 6.05 EV/EBITDA (x) 25.85 27.32 23.54 17.68 23.78 EBITDA Margin (%) 16.18 15.52 23.37 25.86 14.92
Amrutanjan Health Care Peer Comparison
Amrutanjan Health Care Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 13.41% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 13.41% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 13.41% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 13.41% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
110.79
Amount Invested (in Cr.)
0.69%
% of AUM
0.00
% Change (MoM basis)
36.61
Amount Invested (in Cr.)
1.07%
% of AUM
0.00
% Change (MoM basis)
ICICI Pru FMCG Direct-G
Equity: Thematic
2.63
Amount Invested (in Cr.)
0.15%
% of AUM
100.00
% Change (MoM basis)
MF Ownership as on 31 July 2024
Corporate Actions
Amrutanjan Health Care Board Meeting/AGM
Amrutanjan Health Care Dividends
- Others
Meeting Date Announced on Purpose Details Aug 13, 2024 Aug 05, 2024 Board Meeting Quarterly Results May 23, 2024 May 14, 2024 Board Meeting Audited Results & Final Dividend Feb 09, 2024 Feb 01, 2024 Board Meeting Quarterly Results & Interim Dividend Dec 29, 2023 Nov 28, 2023 POM - Nov 10, 2023 Nov 02, 2023 Board Meeting Quarterly Results & Interim Dividend Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 260% 2.6 Sep 13, 2024 May 23, 2024 Interim 100% 1.0 Feb 20, 2024 Feb 06, 2024 Interim 100% 1.0 Nov 23, 2023 Nov 10, 2023 Final 260% 2.6 Sep 14, 2023 May 30, 2023 Interim 100% 1.0 Feb 24, 2023 Feb 07, 2023 All Types Ex-Date Record Date Announced on Details Splits Apr 13, 2018 Apr 16, 2018 Feb 13, 2018 Split: Old FV2.0| New FV:1.0 Splits Oct 25, 2012 Oct 29, 2012 Aug 06, 2012 Split: Old FV10.0| New FV:2.0 Bonus Oct 29, 2001 Nov 16, 2001 Aug 11, 2001 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Dec 21, 1992 Jan 06, 1993 Sep 30, 1993 Bonus Ratio: 1 share(s) for every 3 shares held Bonus - - Sep 22, 2001 Bonus Ratio: 1 share(s) for every 1 shares held
About Amrutanjan Health Care
Amrutanjan Health Care Ltd., incorporated in the year 1936, is a Small Cap company (having a market cap of Rs 2,388.45 Crore) operating in Pharmaceuticals sector. Amrutanjan Health Care Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Raw Materials and Scrap for the year ending 31-Mar-2023. Show More
Executives
Auditors
- SS
S Sambhu Prasad
Chairman & Managing DirectorPSPasumarthi S N Murthi
Non Executive DirectorRPRamaa Prabhakar Arikirevula
Non Executive DirectorGRG Raghavan
Ind. Non-Executive DirectorShow More - BSR & Co. LLP
Industry
Key Indices Listed on
-
Address
No.103 (Old No.42-45),Luz Church Road,Chennai (Madras), Tamil Nadu - 600004
More Details
FAQs about Amrutanjan Health Care share
- 1. What is Amrutanjan Health Care share price and what are the returns for Amrutanjan Health Care share?Amrutanjan Health Care share price was Rs 826.15 as on 29 Aug, 2024, 03:58 PM IST. Amrutanjan Health Care share price was down by 0.74% based on previous share price of Rs. 823.3.
- 2. What is the PE & PB ratio of Amrutanjan Health Care?The PE ratio of Amrutanjan Health Care stands at 56.52, while the PB ratio is 8.34.
- 3. Who are the key owners of Amrutanjan Health Care stock?
- Promoter holding has not changed in last 9 months and holds 50.59 stake as on 30 Jun 2024
- Domestic Institutional Investors holding has gone up from 7.01 (30 Sep 2023) to 7.22 (30 Jun 2024)
- Foreign Institutional Investors holding has gone up from 0.75 (30 Sep 2023) to 1.55 (30 Jun 2024)
- Other investor holding have gone down from 41.65 (30 Sep 2023) to 40.64 (30 Jun 2024)
- 4. What dividend is Amrutanjan Health Care giving?Amrutanjan Health Care Ltd. announced an equity dividend of 260% on a face value of 1.0 amounting to Rs 2.6 per share on 23 May 2024. The ex dividend date is 13 Sep 2024.
- 5. What are the key metrics to analyse Amrutanjan Health Care Share Price?Key Metrics for Amrutanjan Health Care are:
- PE Ratio of Amrutanjan Health Care is 56.10
- Price/Sales ratio of Amrutanjan Health Care is 4.25
- Price to Book ratio of Amrutanjan Health Care is 8.34
- 6. Who is the chairman of Amrutanjan Health Care?S Sambhu Prasad is the Chairman & Managing Director of Amrutanjan Health Care
- 7. What are the returns for Amrutanjan Health Care share?Return Performance of Amrutanjan Health Care Shares:
- 1 Week: Amrutanjan Health Care share price moved up by 8.95%
- 3 Month: Amrutanjan Health Care share price moved up by 18.30%
- 6 Month: Amrutanjan Health Care share price moved up by 29.22%
- 8. Who are the peers for Amrutanjan Health Care in Pharmaceuticals sector?Within Pharmaceuticals sector Amrutanjan Health Care, Themis Medicare Ltd., IOL Chemicals and Pharmaceuticals Ltd., SMS Pharmaceuticals Ltd., Solara Active Pharma Sciences Ltd., Zota Healthcare Ltd., Dishman Carbogen Amcis Ltd., Syncom Formulation (India) Ltd., NGL Fine - Chem Ltd., Suven Life Sciences Ltd. and Lincoln Pharmaceuticals Ltd. are usually compared together by investors for analysis.
- 9. What is the CAGR of Amrutanjan Health Care?The CAGR of Amrutanjan Health Care is 6.06.
- 10. What are the Amrutanjan Health Care quarterly results?On Standalone basis, Amrutanjan Health Care reported a total income and loss of Rs 88.19 Cr and Rs 4.62 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-03-31 was Rs 438.17 Cr and Rs 44.97 Cr.
- 11. What is 52 week high/low of Amrutanjan Health Care share price?52 Week high of Amrutanjan Health Care share is Rs 862.60 while 52 week low is Rs 563.90
- 12. What's the market capitalization of Amrutanjan Health Care?Market Capitalization of Amrutanjan Health Care stock is Rs 2,388.45 Cr.
Trending in Markets
Amrutanjan Health Care Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.